PAMELA WHITENER: Open Payments
NPI 1184643744 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 55 payments from 17 companies in 2025. Trend: 2023 $1,014 · 2024 $892 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $273 |
| Novo Nordisk Inc | 11 | $209 |
| Lilly USA, LLC | 9 | $121 |
| SANOFI-AVENTIS U.S. LLC | 5 | $108 |
| ABBVIE INC. | 4 | $75 |
| Medtronic, Inc. | 3 | $57 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Soleno Therapeutics, Inc. | 1 | $30 |
Products named: AIRSUPRA, TZIELD, Wegovy, MOUNJARO, JARDIANCE, FARXIGA, SYMPLICITY G3, INSPIRE.
Industry payments across TX — which companies pay providers there.
